Cold Armor Spray
NDC Package 71753-1156-1
Package Information
Cold Armor (allium cepa, hydrastis canadensis, pulsatilla (pratensis), dulcamara, nux vomica, ferrum phosphoricum, gelsemium sempervirens, kali bichromicum) sprays is • Adults: 2 sprays 3 times a day or as needed• Children 3-6: 1 spray as above• Consult a physician for use in children under 6 years of age.Store in a cool, dry place. This formulation utilizes a spray delivery system. Marketed by Ratis, Llc, this product is identified by NDC 71753-1156.
Identification & Billing
Clinical Specifications
- Allergens - [CS]
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Dietary Proteins - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Non-Standardized Food Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Seed Storage Proteins - [CS]
- Vegetable Proteins - [CS]
Regulatory & Marketing
Hierarchy Structure
- 71753 - Ratis, Llc
- 71753-1156 - Cold Armor
- 71753-1156-1 - 30 mL in 1 BOTTLE, SPRAY
- 71753-1156 - Cold Armor
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 71753-1156-1 identifies a specific commercial package of 30 ml in 1 bottle, spray of Cold Armor, a human over the counter drug labeled by Ratis, Llc. This spray is formulated for oral use and contains ferrosoferric phosphate; gelsemium sempervirens root; goldenseal; onion; potassium dichromate; pulsatilla pratensis whole; solanum dulcamara top; strychnos nux-vomica seed as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Ratis, Llc on May 26, 2023. The current certification is valid through December 31, 2026.
How is this Ratis, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 71753115601. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.